Dianthus Therapeutics (DNTH) Tops Q2 EPS by 77c

Dianthus Therapeutics (NASDAQ: DNTH) reported Q2 EPS of ($0.09), $0.77 better than the analyst estimate of ($0.86). Revenue for the quarter came in at $760 thousand versus the consensus estimate of $297.42 thousand.

For earnings history and earnings-related data on Dianthus Therapeutics (DNTH) click here.

You May Also Be Interested In

• Yen Jumps More Than 1% To Trade At 158.22 Per Us Dollar
• Ollie's Bargain Outlet (OLLI) Tops Q2 EPS by 28c, Offers Guidance
• GitLab Inc (GTLB) PT Raised to $55 at DA Davidson, Neutral Rating Maintained